"10.1371_journal.pone.0152269","plos one","2016-03-25T00:00:00Z","Line Melgaard; Anders Gorst-Rasmussen; Lars Hvilsted Rasmussen; Gregory Y H Lip; Torben Bjerregaard Larsen","Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Unit of Clinical Biostatistics, Aalborg University Hospital, Aalborg, Denmark; University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark","Conceived and designed the experiments: LM AGR LHR GYHL TBL. Performed the experiments: LM AGR LHR GYHL TBL. Analyzed the data: LM AGR LHR GYHL TBL. Contributed reagents/materials/analysis tools: LM AGR LHR GYHL TBL. Wrote the paper: LM AGR LHR GYHL TBL.","Professor Lip: Consultant for Bayer/Jensen J&J, Astellas, Merck, Sanofi, BMS/Pfizer, Biotronik, Professor Lip: Consultant for Bayer/Jensen J&J, Astellas, Merck, Sanofi, BMS/Pfizer, Biotronik, Medtronic, Portola, Boehringer Ingelheim, Microlife and Daiichi-Sankyo. Speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche and Daiichi-Sankyo. Associate Professor Larsen has served as an investigator for Janssen Scientific Affairs, LLC and Boehringer Ingelheim. Associate Professor Larsen and Professor Rasmussen have been on the speaker bureaus for Bayer, BMS/Pfizer, Janssen Pharmaceuticals, Takeda, Roche Diagnostics and Boehringer Ingelheim. Other authors – none declared. Profs Lip and Larsen are guarantors of this paper. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.","2016","03","Line Melgaard","LM",5,TRUE,5,5,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
